{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:02:00Z","timestamp":1789707720573,"version":"4.0.1"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05049-0","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:07:54Z","timestamp":1782846474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of circulating long noncoding RNAs in hepatocellular carcinoma: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Nastaran","family":"Babajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrad","family":"Saeedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Ojaghi","family":"Shirmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Morteza","family":"Pourfaraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jodeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsaneh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"19","key":"5049_CR1","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/CM9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Li Q, Ding C, Cao M, Yang F, Yan X, He S, et al. Global epidemiology of liver cancer 2022: An emphasis on geographic disparities. Chin Med J (Engl). 2024;137(19):2334\u201342.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"5049_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Reviews Disease Primers. 2021;7(1):6.","journal-title":"Nat Reviews Disease Primers"},{"issue":"2","key":"5049_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","volume":"342","author":"IP Pogribny","year":"2014","unstructured":"Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014;342(2):223\u201330.","journal-title":"Cancer Lett"},{"key":"5049_CR4","doi-asserted-by":"publisher","first-page":"1714314","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li J, Liang YB, Chen XM, Ou ZY, Wang QB, Luo WL, et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front Immunol. 2026;17:1714314.","journal-title":"Front Immunol"},{"key":"5049_CR5","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, et al. Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study. J Hepatocell Carcinoma. 2025;12:2681\u201392.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"5049_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol. 2020;72(2):250\u201361.","journal-title":"J Hepatol"},{"issue":"6","key":"5049_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.20892\/j.issn.2095-3941.2021.0661","volume":"19","author":"T Yan","year":"2022","unstructured":"Yan T, Yu L, Zhang N, Peng C, Su G, Jing Y, et al. The advanced development of molecular targeted therapy for hepatocellular carcinoma. Cancer Biology Med. 2022;19(6):802.","journal-title":"Cancer Biology Med"},{"issue":"5","key":"5049_CR8","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1053\/j.gastro.2004.09.023","volume":"127","author":"B Daniele","year":"2004","unstructured":"Daniele B, Bencivenga A, Megna AS, Tinessa V. \u03b1-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004;127(5):S108\u201312.","journal-title":"Gastroenterology"},{"key":"5049_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"C Sauzay","year":"2016","unstructured":"Sauzay C, Petit A, Bourgeois A-M, Barbare J-C, Chauffert B, Galmiche A, et al. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta. 2016;463:39\u201344.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"5049_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","volume":"28","author":"JD Yang","year":"2019","unstructured":"Yang JD, Addissie BD, Mara KC, Harmsen WS, Dai J, Zhang N, et al. GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiol Biomarkers Prev. 2019;28(3):531\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"5049_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","volume":"18","author":"J Best","year":"2020","unstructured":"Best J, Bechmann LP, Sowa JP, Sydor S, Dech\u00eane A, Pflanz K, et al. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2020;18(3):728\u2013e354.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"5049_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2015.02.035","volume":"360","author":"X Yang","year":"2015","unstructured":"Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang B, et al. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett. 2015;360(2):119\u201324.","journal-title":"Cancer Lett"},{"issue":"9","key":"5049_CR13","doi-asserted-by":"publisher","first-page":"e6222","DOI":"10.1097\/MD.0000000000006222","volume":"96","author":"M Liu","year":"2017","unstructured":"Liu M, Xing LQ, Liu YJ. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Med (Baltim). 2017;96(9):e6222.","journal-title":"Med (Baltim)"},{"issue":"6","key":"5049_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.3854","volume":"35","author":"AH Rizvi","year":"2017","unstructured":"Rizvi AH, Camara PG, Kandror EK, Roberts TJ, Schieren I, Maniatis T, et al. Single-cell topological RNA-seq analysis reveals insights into cellular differentiation and development. Nat Biotechnol. 2017;35(6):551\u201360.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"5049_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ncb3538","volume":"19","author":"JH Yuan","year":"2017","unstructured":"Yuan JH, Liu XN, Wang TT, Pan W, Tao QF, Zhou WP, et al. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 2017;19(7):820\u201332.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"5049_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3892\/ol.2021.12665","volume":"21","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang Y, Yuan S, Wen F, Liu J, Zou L, et al. Regulatory role of long non-coding RNA UCA1 in signaling pathways and its clinical applications. Oncol Lett. 2021;21(5):404.","journal-title":"Oncol Lett"},{"issue":"6","key":"5049_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57(6):833\u201340.","journal-title":"Clin Chem"},{"issue":"14","key":"5049_CR18","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.7150\/jca.24560","volume":"9","author":"L Peng","year":"2018","unstructured":"Peng L, Yuan XQ, Zhang CY, Peng JY, Zhang YQ, Pan X, et al. The emergence of long non-coding RNAs in hepatocellular carcinoma: an update. J Cancer. 2018;9(14):2549\u201358.","journal-title":"J Cancer"},{"issue":"20","key":"5049_CR19","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1158\/0008-5472.CAN-19-0255","volume":"79","author":"LJ Lim","year":"2019","unstructured":"Lim LJ, Wong SYS, Huang F, Lim S, Chong SS, Ooi LL, et al. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019;79(20):5131\u20139.","journal-title":"Cancer Res"},{"issue":"4","key":"5049_CR20","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.18632\/aging.205523","volume":"16","author":"W Liang","year":"2024","unstructured":"Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J. The role of long non-coding RNA in hepatocellular carcinoma. Aging. 2024;16(4):4052\u201373.","journal-title":"Aging"},{"issue":"35","key":"5049_CR21","doi-asserted-by":"publisher","first-page":"59638","DOI":"10.18632\/oncotarget.19559","volume":"8","author":"C Zheng","year":"2017","unstructured":"Zheng C, Liu X, Chen L, Xu Z, Shao J. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8(35):59638\u201347.","journal-title":"Oncotarget"},{"issue":"8","key":"5049_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"10","key":"5049_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982\u201390.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"5049_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/sim.2992","volume":"27","author":"AH Zwinderman","year":"2008","unstructured":"Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med. 2008;27(5):687\u201397.","journal-title":"Stat Med"},{"key":"5049_CR25","first-page":"1","volume":"49","author":"H Holling","year":"2019","unstructured":"Holling H, B\u00f6hning W, Masoudi E, Boehning D, Sangnawakij P. Evaluation of a new version of I 2 with emphasis on diagnostic problems. Commun Stat - Simul Comput. 2019;49:1\u201331.","journal-title":"Commun Stat - Simul Comput"},{"issue":"4","key":"5049_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/biom.13343","volume":"76","author":"H Noma","year":"2020","unstructured":"Noma H. Discussion on Testing Small Study Effects in Multivariate Meta-Analysis by Chuan Hong, Georgia Salanti, Sally Morton, Richard Riley, Haitao Chu, Stephen E. Kimmel, and Yong Chen. Biometrics. 2020;76(4):1255\u20139.","journal-title":"Biometrics"},{"key":"5049_CR27","doi-asserted-by":"crossref","unstructured":"Noma H. MVPBT: R package for publication bias tests in meta-analysis of diagnostic accuracy studies. arXiv [statCO]; 2022.","DOI":"10.32614\/CRAN.package.MVPBT"},{"issue":"3","key":"5049_CR28","first-page":"344","volume":"7","author":"H Noma","year":"2021","unstructured":"Noma H, Matsushima Y, Ishii R. Confidence interval for the AUC of SROC curve and some related methods using bootstrap for meta-analysis of diagnostic accuracy studies. Commun Statistics: Case Stud Data Anal Appl. 2021;7(3):344\u201358.","journal-title":"Commun Statistics: Case Stud Data Anal Appl"},{"issue":"3","key":"5049_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"key":"5049_CR30","doi-asserted-by":"publisher","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. BMJ Mental Health. 2019;22(4). https:\/\/doi.org\/10.1136\/ebmental-2019-300117.","DOI":"10.1136\/ebmental-2019-300117"},{"issue":"10","key":"5049_CR31","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1002\/jcb.27109","volume":"119","author":"A Abd El Gwad","year":"2018","unstructured":"Abd El Gwad A, Matboli M, El-Tawdi A, Habib EK, Shehata H, Ibrahim D, et al. Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma. J Cell Biochem. 2018;119(10):8600\u201310.","journal-title":"J Cell Biochem"},{"key":"5049_CR32","doi-asserted-by":"publisher","unstructured":"Abdelsattar S, Fahim SA, Kamel HFM, Al-Amodi H, Kasemy ZA, Khalil FO, et al. The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma. Non-Coding Rna. 2023;9(5):62. https:\/\/doi.org\/10.3390\/ncrna9050062.","DOI":"10.3390\/ncrna9050062"},{"issue":"5","key":"5049_CR33","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1016\/j.ygeno.2020.06.020","volume":"112","author":"HS Ali","year":"2020","unstructured":"Ali HS, Boshra MS, El Meteini MS, Shafei AE, Matboli M. lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR\/Cas9 editing in hepatocellular carcinoma. Genomics. 2020;112(5):3306\u201314.","journal-title":"Genomics"},{"issue":"3","key":"5049_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mc.23488","volume":"62","author":"MA Ali","year":"2023","unstructured":"Ali MA, Shaker OG, Ezzat EM, Eid HM, Ali DY, Hassan EA, et al. Serum lncRNAs, NBAT-1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C. Mol Carcinog. 2023;62(3):319\u201331.","journal-title":"Mol Carcinog"},{"key":"5049_CR35","doi-asserted-by":"publisher","unstructured":"Badr EAE, Elmongy EI, Mostafa RG, El-Sayed IE, Abd El-Ati Gad Allah AE, Khairy Ahmed A, et al. The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular Carcinoma. Biomedicines. 2022;11(1):56. https:\/\/doi.org\/10.3390\/biomedicines11010056.","DOI":"10.3390\/biomedicines11010056"},{"key":"5049_CR36","doi-asserted-by":"publisher","first-page":"107327482412848","DOI":"10.1177\/10732748241284821","volume":"31","author":"H Bao","year":"2024","unstructured":"Bao H, Jiang Y, Wang N, Su H, Han X. Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma. Cancer Control. 2024;31:10732748241284821.","journal-title":"Cancer Control"},{"issue":"3","key":"5049_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/CBM-220033","volume":"35","author":"CC Bongolo","year":"2022","unstructured":"Bongolo CC, Thokerunga E, Fidele NB, Souraka TDM, Kisembo P, Rugera SP, et al. Upregulation of the long non-coding RNA, LIPCAR promotes proliferation, migration, and metastasis of hepatocellular carcinoma. Cancer Biomark. 2022;35(3):245\u201356.","journal-title":"Cancer Biomark"},{"key":"5049_CR38","doi-asserted-by":"crossref","unstructured":"Cao S, Zhong F, Chen X, Ke S, Zhong X, Li T et al. The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma. Mol Med Rep. 2025;31(2).","DOI":"10.3892\/mmr.2024.13409"},{"issue":"1","key":"5049_CR39","doi-asserted-by":"publisher","first-page":"e24143","DOI":"10.1002\/jcla.24143","volume":"36","author":"J Chen","year":"2022","unstructured":"Chen J, Tang D, Li H, Zhang P. Expression changes of serum LINC00941 and LINC00514 in HBV infection-related liver diseases and their potential application values. J Clin Lab Anal. 2022;36(1):e24143.","journal-title":"J Clin Lab Anal"},{"key":"5049_CR40","doi-asserted-by":"publisher","first-page":"1817694","DOI":"10.1155\/2022\/1817694","volume":"2022","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang J, Liu J, Wang J, Shi C, Lu L, et al. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. J Immunol Res. 2022;2022:1817694.","journal-title":"J Immunol Res"},{"issue":"6","key":"5049_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/abbs\/gmz046","volume":"51","author":"H Dong","year":"2019","unstructured":"Dong H, Zhang Y, Xu Y, Ma RX, Liu LQ, Luo CJ, et al. Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-\u03b21. Acta Biochim Biophys Sin. 2019;51(6):645\u201352.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"2","key":"5049_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5114\/ceh.2022.116820","volume":"8","author":"A El-Shendidi","year":"2022","unstructured":"El-Shendidi A, Ghazala R, Hassouna E. Circulating HOTAIR potentially predicts hepatocellular carcinoma in cirrhotic liver and prefigures the tumor stage. Clin Exp Hepatol. 2022;8(2):139\u201346.","journal-title":"Clin Exp Hepatol"},{"issue":"7","key":"5049_CR43","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/17474124.2016.1193003","volume":"10","author":"AHF El-Tawdi","year":"2016","unstructured":"El-Tawdi AHF, Matboli M, El-Nakeep S, Azazy AEM, Abdel-Rahman O. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2016;10(7):869\u201377.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"5049_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40291-016-0200-9","volume":"20","author":"AHF El-Tawdi","year":"2016","unstructured":"El-Tawdi AHF, Matboli M, Shehata HH, Tash F, El-Khazragy N, Azazy AESM, et al. Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma. Mol Diagnosis Therapy. 2016;20(3):265\u201377.","journal-title":"Mol Diagnosis Therapy"},{"key":"5049_CR45","doi-asserted-by":"publisher","unstructured":"El-Araby RE, Roshdy F, Zaghloul M, Saad AAE, Morsi MH, Radwan WM, et al. Interaction between HOTTIP, H19, and HOTAIR long noncoding RNAs and miRNA-152 in cases of HCC caused by HCV infection. Beni-Suef Univ J Basic Appl Sci. 2024;13(1):42. https:\/\/doi.org\/10.1186\/s43088-024-00499-5.","DOI":"10.1186\/s43088-024-00499-5"},{"issue":"10","key":"5049_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/ijc.34201","volume":"151","author":"P Fu","year":"2022","unstructured":"Fu P, Gong BB, Li HM, Luo Q, Huang ZK, Shan RF, et al. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma. Int J Cancer. 2022;151(10):1824\u201334.","journal-title":"Int J Cancer"},{"key":"5049_CR47","doi-asserted-by":"crossref","unstructured":"Gaber DA, Shaker O, Younis AT, El-Kassas M. LncRNA HULC and miR-122 Expression Pattern in HCC-Related HCV Egyptian Patients. Genes (Basel). 2022;13(9).","DOI":"10.3390\/genes13091669"},{"issue":"3","key":"5049_CR48","first-page":"3305","volume":"18","author":"SB Gao","year":"2018","unstructured":"Gao SB, Xu XH, Wang Y, Zhang W, Wang XY. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma. Mol Med Rep. 2018;18(3):3305\u201313.","journal-title":"Mol Med Rep"},{"issue":"5","key":"5049_CR49","doi-asserted-by":"publisher","first-page":"e0303314","DOI":"10.1371\/journal.pone.0303314","volume":"19","author":"RM Golam","year":"2024","unstructured":"Golam RM, Khalil MAF, Shaker OG, Ahmed TI, Elguaad MKA, Hassan EA, et al. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma. PLoS ONE. 2024;19(5):e0303314.","journal-title":"PLoS ONE"},{"issue":"4","key":"5049_CR50","first-page":"2567","volume":"14","author":"AA Gong","year":"2022","unstructured":"Gong AA, Luo XH, Tan YW, Chen H, Luo GJ. High expression of C10orf91 and LINC01224 in hepatocellular carcinoma and poor prognosis. Am J Translational Res. 2022;14(4):2567\u201379.","journal-title":"Am J Translational Res"},{"issue":"11","key":"5049_CR51","first-page":"12088","volume":"11","author":"L Gong","year":"2018","unstructured":"Gong L, Zhu X, Zhang W, Ni HH, Yin WH, Fu MY. Plasma lncRNAs acting as fingerprints in predicting hepatocellular carcinoma from HBV positive chronic hepatitis. Int J Clin Exp Med. 2018;11(11):12088\u201396.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"5049_CR52","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1007\/s11033-019-04810-x","volume":"46","author":"A Habieb","year":"2019","unstructured":"Habieb A, Matboli M, El-Tayeb H, El-Asmar F. Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma. Mol Biol Rep. 2019;46(4):4581\u201390.","journal-title":"Mol Biol Rep"},{"key":"5049_CR53","doi-asserted-by":"publisher","unstructured":"Huang L, Li X, Gao W. Long non-coding RNA linc-ITGB1 promotes cell proliferation, migration, and invasion in human hepatoma carcinoma by up-regulating ROCK1. Biosci Rep. 2018;38(5):BSR20181289. https:\/\/doi.org\/10.1042\/BSR20181289.","DOI":"10.1042\/BSR20181289"},{"key":"5049_CR54","doi-asserted-by":"publisher","unstructured":"Huang JL, Zheng YS, Xiao XL, Liu C, Lin JP, Zheng SJ, et al. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma. Disease Markers. 2020;2020(1):5417598. https:\/\/doi.org\/10.1155\/2020\/5417598.","DOI":"10.1155\/2020\/5417598"},{"issue":"3","key":"5049_CR55","first-page":"1304","volume":"21","author":"LJ Jiang","year":"2020","unstructured":"Jiang LJ, He YF, Shen GF, Ni JD, Xia ZY, Liu HJ, et al. lncRNA HAND2-AS1 mediates the downregulation of ROCK2 in hepatocellular carcinoma and inhibits cancer cell proliferation, migration and invasion. Mol Med Rep. 2020;21(3):1304\u20139.","journal-title":"Mol Med Rep"},{"issue":"2","key":"5049_CR56","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/or.2016.4859","volume":"36","author":"W Jing","year":"2016","unstructured":"Jing W, Gao SS, Zhu M, Luo P, Jing X, Chai HY, et al. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. Oncol Rep. 2016;36(2):1085\u201392.","journal-title":"Oncol Rep"},{"key":"5049_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.trsl.2015.10.002","volume":"168","author":"MM Kamel","year":"2016","unstructured":"Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Transl Res. 2016;168:134\u201345.","journal-title":"Transl Res"},{"key":"5049_CR58","doi-asserted-by":"publisher","unstructured":"Khalil MMIM, Seddik RM, Mansour MM, Elbasuony HAA, El Derbaly SA. Detection and validity of long non-coding RNAs HOST2, HOTAIR, HOXA-AS2, and MALAT1 as biomarkers for hepatocellular carcinoma. Hum Gene. 2024;42:10. https:\/\/doi.org\/10.1016\/j.humgen.2024.201349.","DOI":"10.1016\/j.humgen.2024.201349"},{"issue":"2","key":"5049_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cas.12854","volume":"107","author":"H Konishi","year":"2016","unstructured":"Konishi H, Ichikawa D, Yamamoto Y, Arita T, Shoda K, Hiramoto H, et al. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci. 2016;107(2):149\u201354.","journal-title":"Cancer Sci"},{"key":"5049_CR60","doi-asserted-by":"publisher","unstructured":"Kunadirek P, Pinjaroen N, Nookaew I, Tangkijvanich P, Chuaypen N. Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Int J Mol Sci. 2022;23(14):7882. https:\/\/doi.org\/10.3390\/ijms23147882.","DOI":"10.3390\/ijms23147882"},{"key":"5049_CR61","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.2147\/OTT.S254455","volume":"13","author":"YW Li","year":"2020","unstructured":"Li YW, Li GY, Chen X, Huang HL, Liao L, Yuan T, et al. A Novel lncRNA NONHSAT053785 Acts as an Independent Risk Factor for Intrahepatic Metastasis of Hepatocellular Carcinoma. Oncotargets Therapy. 2020;13:5455\u201366.","journal-title":"Oncotargets Therapy"},{"key":"5049_CR62","doi-asserted-by":"publisher","unstructured":"Liao L, Chen X, Huang HL, Li YW, Huang Q, Song Z, et al. Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma. BMC Gastroenterol. 2023;23(1). https:\/\/doi.org\/10.1186\/s12876-023-02868-3.","DOI":"10.1186\/s12876-023-02868-3"},{"issue":"4","key":"5049_CR63","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1080\/02648725.2023.2204706","volume":"40","author":"YH Lin","year":"2024","unstructured":"Lin YH, Zhang BY, Su LF, Wei JF, Chen ZC, Wu M. Expression of lncRNA DLX6-AS1 in patients with hepatic carcinoma and its prognostic value. Biotechnol Genet Eng Rev. 2024;40(4):3976\u201387.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"5049_CR64","doi-asserted-by":"publisher","unstructured":"Liu YJ, Zhang Y, Zhang TJ. Long Non-Coding RNA MACC1-AS1 Is Involved in Distant Recurrence of Hepatocellular Carcinoma After Surgical Resection. Med Sci Monit. 2020;26:e921175. https:\/\/doi.org\/10.12659\/MSM.921175.","DOI":"10.12659\/MSM.921175"},{"issue":"9","key":"5049_CR65","doi-asserted-by":"publisher","first-page":"264","DOI":"10.31083\/j.fbl2709264","volume":"27","author":"ZH Lou","year":"2022","unstructured":"Lou ZH, Xu KY, Qiao L, Su XQ, Ou-Yang Y, Miao LB, et al. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. Front Biosci (Landmark Ed). 2022;27(9):264.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"5049_CR66","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s13277-014-2951-4","volume":"36","author":"JJ Lu","year":"2015","unstructured":"Lu JJ, Xie F, Geng L, Shen WF, Sui CJ, Yang JM. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. Tumor Biology. 2015;36(5):3231\u20136.","journal-title":"Tumor Biology"},{"key":"5049_CR67","doi-asserted-by":"publisher","unstructured":"Luo P, Liang CZ, Zhang XW, Liu XF, Wang YC, Wu MM, et al. Identification of long non-coding RNA\u2009<\u2009i>ZFAS1\u2009as a novel biomarker for diagnosis of HCC. Biosci Rep. 2018;38(4):BSR20171359. https:\/\/doi.org\/10.1042\/BSR20171359.","DOI":"10.1042\/BSR20171359"},{"issue":"8","key":"5049_CR68","doi-asserted-by":"publisher","first-page":"13494","DOI":"10.1002\/jcb.28623","volume":"120","author":"JC Ma","year":"2019","unstructured":"Ma JC, Qin CY, Yuan ZG, Liu SL. LncRNA PAPAS promotes hepatocellular carcinoma by interacting with miR-188-5p. J Cell Biochem. 2019;120(8):13494\u2013500.","journal-title":"J Cell Biochem"},{"issue":"1","key":"5049_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1389202920666191210111849","volume":"21","author":"M Matboli","year":"2020","unstructured":"Matboli M, Labib ME, Nasser HET, El-Tawdi AHF, Habib EK, Ali-Labib R. Exosomal miR-1298 and lncRNA-RP11-583F2.2 Expression in Hepato-cellular Carcinoma. Curr Genom. 2020;21(1):46\u201355.","journal-title":"Curr Genom"},{"key":"5049_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clinbiochem.2022.06.006","volume":"108","author":"CJ Mo","year":"2022","unstructured":"Mo CJ, Wu JR, Sui JZ, Deng Y, Li M, Cao Z, et al. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma. Clin Biochem. 2022;108:56\u201362.","journal-title":"Clin Biochem"},{"issue":"1","key":"5049_CR71","first-page":"11","volume":"26","author":"SR Mohammed","year":"2022","unstructured":"Mohammed SR, Shaker OG, Mohamed MM, Mostafa MNA, Gaber SN, Ali DY, et al. The emerging role of lncRNA MEG3 and MEG3 rs7158663 in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2022;26(1):11\u201321.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5049_CR72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clinbiochem.2020.06.005","volume":"84","author":"M Mohyeldeen","year":"2020","unstructured":"Mohyeldeen M, Ibrahim S, Shaker O, Helmy H. Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma. Clin Biochem. 2020;84:38\u201344.","journal-title":"Clin Biochem"},{"key":"5049_CR73","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3889\/oamjms.2021.5909","volume":"9","author":"A Mostafa","year":"2021","unstructured":"Mostafa A, Ibrahim NE, Sabry D, Fathy W, Elkazaz AY. Insulin-like growth factor initiates hepatocellular carcinoma in chronic hepatitis c virus patients through induction of long non-coding ribonucleic acids af085935. Open Access Macedonian J Med Sci. 2021;9:222\u20138.","journal-title":"Open Access Macedonian J Med Sci"},{"issue":"9","key":"5049_CR74","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1002\/jcb.28726","volume":"120","author":"TMK Motawi","year":"2019","unstructured":"Motawi TMK, El-Maraghy SA, Sabry D, Mehana NA. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. J Cell Biochem. 2019;120(9):14645\u201356.","journal-title":"J Cell Biochem"},{"key":"5049_CR75","doi-asserted-by":"crossref","unstructured":"Pan Y, Cai M, Zhang F, Liu XM, Li MH, Xie BX, et al. Diagnostic Significance of Serum Long Noncoding HOX Antisense Intergenic Ribonucleic Acid in Patients with Hepatitis B Virus Related Hepatocellular Carcinoma. Turkish J Gastroenterol. 2024;35(5):391\u2013397.","DOI":"10.5152\/tjg.2024.23314"},{"issue":"8","key":"5049_CR76","first-page":"11984","volume":"10","author":"YS Qin","year":"2017","unstructured":"Qin YS, Wu J, Ke ZG, Xu JH. Expression of plasma lncRNA BANCR in hepatocellular carcinoma and its diagnostic and prognostic significance. Int J Clin Exp Med. 2017;10(8):11984\u201390.","journal-title":"Int J Clin Exp Med"},{"key":"5049_CR77","doi-asserted-by":"publisher","unstructured":"Ramadan A, Abdelaziz AO, Sabry D, Fathi SAE, Nabeel MM, Shousha HI, et al. Study on molecular expression of long non-coding RNA Glypican3 in hepatocellular cancer patients. Egypt Liver J. 2022;12(58). https:\/\/doi.org\/10.1186\/s43066-022-00221-z.","DOI":"10.1186\/s43066-022-00221-z"},{"issue":"3","key":"5049_CR78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.21608\/ejhm.2021.146640","volume":"82","author":"NM Rashad","year":"2021","unstructured":"Rashad NM, Ahmed SM, Hussien MHS, Amer MG, Ibrahim NF. Association of circulatory long non-coding RNA AFAP1-AS1 with risk and progression of hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection. Egypt J Hosp Med. 2021;82(3):416\u201325.","journal-title":"Egypt J Hosp Med"},{"issue":"9","key":"5049_CR79","doi-asserted-by":"publisher","first-page":"e3112","DOI":"10.1002\/jgm.3112","volume":"21","author":"NS Refai","year":"2019","unstructured":"Refai NS, Louka ML, Halim HY, Montasser I. Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance. J Gene Med. 2019;21(9):e3112.","journal-title":"J Gene Med"},{"issue":"6","key":"5049_CR80","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/liv.15230","volume":"42","author":"A Rojas","year":"2022","unstructured":"Rojas A, Gil-G\u00f3mez A, de la Cruz-ojeda P, Mu\u00f1oz-Hern\u00e1ndez R, S\u00e1nchez-Torrijos Y, Gallego-Dur\u00e1n R, et al. Long non-coding RNA\u2009<\u2009i>H19\u2009as a biomarker for hepatocellular carcinoma. Liver Int. 2022;42(6):1410\u201322.","journal-title":"Liver Int"},{"key":"5049_CR81","doi-asserted-by":"publisher","unstructured":"Roshdy F, Farag MMS, El-Ahwany E, Mahmode O, Mousa AA, El Talkawy M, et al. Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma. Egypt J Med Hum Genet. 2020;21(7). https:\/\/doi.org\/10.1186\/s43042-020-0048-8.","DOI":"10.1186\/s43042-020-0048-8"},{"issue":"10","key":"5049_CR82","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1002\/1878-0261.13049","volume":"15","author":"SS Kim","year":"2021","unstructured":"Kim SS, Baek GO, Son JA, Ahn HR, Yoon MK, Cho HJ, et al. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers. Mol Oncol. 2021;15(10):2715\u201331.","journal-title":"Mol Oncol"},{"issue":"10","key":"5049_CR83","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/1878-0261.12745","volume":"14","author":"SS Kim","year":"2020","unstructured":"Kim SS, Baek GO, Ahn HR, Sung SN, Seo CW, Cho HJ, et al. Serum small extracellular vesicle-derived\u2009<\u2009i>LINC00853\u2009as a novel diagnostic marker for early hepatocellular carcinoma. Mol Oncol. 2020;14(10):2646\u201359.","journal-title":"Mol Oncol"},{"issue":"4","key":"5049_CR84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5114\/ceh.2021.111060","volume":"7","author":"HS Sabry","year":"2021","unstructured":"Sabry HS, Tayel SI, Enar ME, Elabd NS. Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections. Clin Exp Hepatol. 2021;7(4):337\u201350.","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"5049_CR85","doi-asserted-by":"publisher","first-page":"29582","DOI":"10.1038\/s41598-024-80926-w","volume":"14","author":"A Samir","year":"2024","unstructured":"Samir A, Abdeldaim A, Mohammed A, Ali A, Alorabi M, Hussein MM, et al. Analysis of four long non-coding RNAs for hepatocellular carcinoma screening and prognosis by the aid of machine learning techniques. Sci Rep. 2024;14(1):29582.","journal-title":"Sci Rep"},{"issue":"10","key":"5049_CR86","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/iub.2096","volume":"71","author":"OG Shaker","year":"2019","unstructured":"Shaker OG, Abdelwahed MY, Ahmed NA, Hassan EA, Ahmed TI, Abousarie MA, et al. Evaluation of serum long noncoding RNA NEAT and MiR-129-5p in hepatocellular carcinoma. IUBMB Life. 2019;71(10):1571\u20138.","journal-title":"IUBMB Life"},{"key":"5049_CR87","doi-asserted-by":"publisher","unstructured":"Shaker OG, Khairy AM, Ali RMM, Badr AM. miRNA-141 and its target long non-coding RNA HOTAIR as diagnostic marker in hepatocellular carcinoma on top of hepatitis C virus. Gene Rep. 2020;21:100807. https:\/\/doi.org\/10.1016\/j.genrep.2020.100807.","DOI":"10.1016\/j.genrep.2020.100807"},{"key":"5049_CR88","first-page":"137","volume":"17","author":"S Shehab-Eldeen","year":"2023","unstructured":"Shehab-Eldeen S, Essa A, Arafat ES, Sleem AS, Alhosary AA, Darwish E, et al. Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value. Biologics. 2023;17:137\u201349.","journal-title":"Biologics"},{"key":"5049_CR89","doi-asserted-by":"publisher","unstructured":"Soliman SE, ElTorgoman AMA, Assar MFA, El Abd NS, Gohar SF, Girgis RE. Biochemical and molecular study of long non-coding RNAs (HOTTIP, ZEB-AS1 and MEG-3) in hepatocellular carcinoma. Meta Gene. 2020;26:100808. https:\/\/doi.org\/10.1016\/j.mgene.2020.100808.","DOI":"10.1016\/j.mgene.2020.100808"},{"issue":"15","key":"5049_CR90","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.7150\/jca.24978","volume":"9","author":"L Sun","year":"2018","unstructured":"Sun L, Su YY, Liu XX, Xu M, Chen XX, Zhu YF, et al. Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma. J Cancer. 2018;9(15):2631\u20139.","journal-title":"J Cancer"},{"issue":"4","key":"5049_CR91","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3103\/S0891416822040061","volume":"37","author":"RSZ Taleb","year":"2022","unstructured":"Taleb RSZ, Zeid AE, Nabil MA, Moez PE. Plasma Long Non-Coding RNA\u2009<\u2009i>ZFAS1\u2009as a Potential Diagnostic Biomarker for HCV-Related Hepatocellular Carcinoma. Mol Genet Microbiol Virol. 2022;37(4):242\u20137.","journal-title":"Mol Genet Microbiol Virol"},{"issue":"2","key":"5049_CR92","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clinre.2016.09.002","volume":"41","author":"WJ Ma","year":"2017","unstructured":"Ma WJ, Wang HT, Jing W, Zhou FL, Chang L, Hong ZF, et al. Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2017;41(2):163\u201370.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"5049_CR93","doi-asserted-by":"publisher","first-page":"e0144934","DOI":"10.1371\/journal.pone.0144934","volume":"10","author":"K Wang","year":"2015","unstructured":"Wang K, Guo WX, Li N, Gao CF, Shi J, Tang YF, et al. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. PLoS ONE. 2015;10(12):e0144934.","journal-title":"PLoS ONE"},{"issue":"12","key":"5049_CR94","doi-asserted-by":"publisher","first-page":"11550","DOI":"10.18632\/aging.103302","volume":"12","author":"JC Wang","year":"2020","unstructured":"Wang JC, Pu J, Zhang Y, Yao TW, Luo ZJ, Li WC, et al. Exosome-transmitted long non-coding RNA\u2009<\u2009i>SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma. Aging-Us. 2020;12(12):11550\u201367.","journal-title":"Aging-Us"},{"key":"5049_CR95","doi-asserted-by":"crossref","unstructured":"Wang T, Zhu HK, Xiao M, Zhou S. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma. J Clin Lab Anal. 2021;35(11).","DOI":"10.1002\/jcla.23959"},{"issue":"9","key":"5049_CR96","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11427-017-9054-y","volume":"60","author":"C Wang","year":"2017","unstructured":"Wang C, Ren TY, Wang KY, Zhang SG, Liu SB, Chen H, et al. Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. Sci China-Life Sci. 2017;60(9):1047\u201350.","journal-title":"Sci China-Life Sci"},{"key":"5049_CR97","doi-asserted-by":"publisher","unstructured":"Wang ZH, Gao P, Sun WJ, Rehman AU, Jiang JK, Xu SB, et al. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Front Endocrinol. 2023;14:e23959. https:\/\/doi.org\/10.1002\/jcla.23959.","DOI":"10.1002\/jcla.23959"},{"issue":"9","key":"5049_CR98","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1111\/cas.14516","volume":"111","author":"XJ Huang","year":"2020","unstructured":"Huang XJ, Sun LY, Wen S, Deng DL, Wan FJ, He X, et al. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Cancer Sci. 2020;111(9):3338\u201349.","journal-title":"Cancer Sci"},{"issue":"12","key":"5049_CR99","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.21873\/anticanres.11236","volume":"36","author":"X Ma","year":"2016","unstructured":"Ma X, Wang X, Yang C, Wang ZS, Han B, Wu LQ, et al. DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma. Anticancer Res. 2016;36(12):6389\u201398.","journal-title":"Anticancer Res"},{"key":"5049_CR100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ebiom.2018.06.026","volume":"33","author":"ZJ Xie","year":"2018","unstructured":"Xie ZJ, Zhou FY, Yang YD, Li LJ, Lei YM, Lin XY, et al. Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. Ebiomedicine. 2018;33:57\u201367.","journal-title":"Ebiomedicine"},{"key":"5049_CR101","doi-asserted-by":"publisher","unstructured":"Xu XY, Gu JM, Ding XG, Ge GH, Zang XY, Ji RB, et al. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Cell Death Dis. 2019;10:752. https:\/\/doi.org\/10.1038\/s41419-019-1990-6.","DOI":"10.1038\/s41419-019-1990-6"},{"issue":"6","key":"5049_CR102","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1055-9965.EPI-17-0770","volume":"27","author":"H Xu","year":"2018","unstructured":"Xu H, Chen YM, Dong XY, Wang XJ. Serum Exosomal Long Noncoding RNAs\u2009<\u2009i>ENSG00000258332.<i\u2009>\u20091\u2009and LINC00635\u2009for the Diagnosis and Prognosis of Hepatocellular Carcinoma<\/i\u2009>. Cancer Epidemiol Biomarkers Prev. 2018;27(6):710\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"5049_CR103","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/CBM-170781","volume":"22","author":"YC Wang","year":"2018","unstructured":"Wang YC, Jing W, Ma WJ, Liang CZ, Chai HY, Tu JC. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Cancer Biomarkers. 2018;22(2):227\u201336.","journal-title":"Cancer Biomarkers"},{"issue":"48","key":"5049_CR104","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.3748\/wjg.v25.i48.6902","volume":"25","author":"YL Zeng","year":"2019","unstructured":"Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol. 2019;25(48):6902\u201315.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"5049_CR105","doi-asserted-by":"publisher","first-page":"11843","DOI":"10.18632\/aging.103355","volume":"12","author":"ZC Yao","year":"2020","unstructured":"Yao ZC, Jia CC, Tai Y, Liang H, Zhong ZZ, Xiongl ZY, et al. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Aging-Us. 2020;12(12):11843\u201363.","journal-title":"Aging-Us"},{"issue":"1","key":"5049_CR106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000484589","volume":"44","author":"WD Yuan","year":"2017","unstructured":"Yuan WD, Sun Y, Liu L, Zhou B, Wang SM, Gu DH. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma. Cell Physiol Biochem. 2017;44(1):125\u201332.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"5049_CR107","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1080\/21691401.2019.1640228","volume":"47","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Dong JH, Li YY, Dong Z, Liu Z, Huang JG, et al. The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2019;47(1):3067\u201371.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"5049_CR108","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1159\/000488841","volume":"46","author":"B Zeng","year":"2018","unstructured":"Zeng B, Lin ZW, Ye HL, Cheng D, Zhang GT, Zhou JD, et al. Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC. Cell Physiol Biochem. 2018;46(3):1122\u201333.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"5049_CR109","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0300060517726441","volume":"46","author":"ZK Zheng","year":"2018","unstructured":"Zheng ZK, Pang C, Yang Y, Duan Q, Zhang J, Liu WC. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 2018;46(1):348\u201356.","journal-title":"J Int Med Res"},{"issue":"2","key":"5049_CR110","first-page":"1593","volume":"16","author":"ZF Wang","year":"2018","unstructured":"Wang ZF, Hu R, Pang JM, Zhang GZ, Yan W, Li ZN. Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma. Oncol Lett. 2018;16(2):1593\u2013601.","journal-title":"Oncol Lett"},{"key":"5049_CR111","doi-asserted-by":"publisher","unstructured":"Zhu XY, Feng YL, He DD, Wang Z, Huang FF, Tu JC. Clinical Value and Underlying Mechanisms of Upregulated\u2009<\u2009i>LINC00485\u2009in Hepatocellular Carcinoma. Front Oncol. 2021;11:654424. https:\/\/doi.org\/10.3389\/fonc.2021.654424.","DOI":"10.3389\/fonc.2021.654424"},{"key":"5049_CR112","doi-asserted-by":"publisher","unstructured":"Attia AM, Rezaee-Zavareh MS, Hwang SY, Kim N, Adetyan H, Yalda T, et al. Novel Biomarkers for Early Detection of Hepatocellular Carcinoma. Diagnostics (Basel). 2024;14(20):2278. https:\/\/doi.org\/10.3390\/diagnostics14202278.","DOI":"10.3390\/diagnostics14202278"},{"key":"5049_CR113","doi-asserted-by":"publisher","unstructured":"Eun JW, Cheong JY, Jeong JY, Kim HS. A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m(6)A Modification to Blood Biomarkers. Cells. 2023;12(18):2272. https:\/\/doi.org\/10.3390\/cells12182272.","DOI":"10.3390\/cells12182272"},{"issue":"1","key":"5049_CR114","first-page":"8410195","volume":"2018","author":"S Chen","year":"2018","unstructured":"Chen S, Zhang Y, Wu X, Zhang C, Li G. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis. Can J Gastroenterol Hepatol. 2018;2018(1):8410195.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"22","key":"5049_CR115","doi-asserted-by":"publisher","first-page":"12235","DOI":"10.3390\/ijms252212235","volume":"25","author":"F Tonon","year":"2024","unstructured":"Tonon F, Grassi C, Tierno D, Biasin A, Grassi M, Grassi G, et al. Non-Coding RNAs as Potential Diagnostic\/Prognostic Markers for Hepatocellular Carcinoma. Int J Mol Sci. 2024;25(22):12235.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5049_CR116","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/ijms25021258","volume":"25","author":"L Lumkul","year":"2024","unstructured":"Lumkul L, Jantaree P, Jaisamak K, Wongkummool W, Lapisatepun W, Orrapin S, et al. Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2024;25(2):1258.","journal-title":"Int J Mol Sci"},{"key":"5049_CR117","doi-asserted-by":"publisher","unstructured":"Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY, et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med. 2026;57(3). https:\/\/doi.org\/10.3892\/ijmm.2026.5729.","DOI":"10.3892\/ijmm.2026.5729"},{"key":"5049_CR118","doi-asserted-by":"publisher","first-page":"1483521","DOI":"10.3389\/fonc.2024.1483521","volume":"14","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Qi S, Zhang R, Zhao R, Fu Y, Fang Y, et al. Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis. Front Oncol. 2024;14:1483521.","journal-title":"Front Oncol"},{"issue":"28","key":"5049_CR119","doi-asserted-by":"publisher","first-page":"e7496","DOI":"10.1097\/MD.0000000000007496","volume":"96","author":"QQ Hao","year":"2017","unstructured":"Hao QQ, Chen GY, Zhang JH, Sheng JH, Gao Y. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis. Med (Baltim). 2017;96(28):e7496.","journal-title":"Med (Baltim)"},{"issue":"23","key":"5049_CR120","doi-asserted-by":"publisher","first-page":"E5334","DOI":"10.1073\/pnas.1714397115","volume":"115","author":"KEA Max","year":"2018","unstructured":"Max KEA, Bertram K, Akat KM, Bogardus KA, Li J, Morozov P, et al. Human plasma and serum extracellular small RNA reference profiles and their clinical utility. Proc Natl Acad Sci U S A. 2018;115(23):E5334\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5049_CR121","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.fob.2015.03.010","volume":"5","author":"SY Zhang","year":"2015","unstructured":"Zhang SY, Lin BD, Li BR. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma. FEBS Open Bio. 2015;5:240\u20134.","journal-title":"FEBS Open Bio"},{"issue":"2","key":"5049_CR122","doi-asserted-by":"publisher","first-page":"e0228857","DOI":"10.1371\/journal.pone.0228857","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen G, Zhang P, Zhang J, Li X, Gan D, et al. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE. 2020;15(2):e0228857.","journal-title":"PLoS ONE"},{"issue":"1","key":"5049_CR123","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12876-024-03260-5","volume":"24","author":"D Xiang","year":"2024","unstructured":"Xiang D, Fu L, Yang Y, Liu C, He Y. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis. BMC Gastroenterol. 2024;24(1):178.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"5049_CR124","first-page":"559","volume":"15","author":"M Lubis","year":"2024","unstructured":"Lubis M, Darmadi D, Surja SS, Pakpahan C. Diagnostic value of Midkine and AFP in the detection of hepatocellular carcinoma: A systematic review and meta-analysis. Caspian J Intern Med. 2024;15(4):559\u201369.","journal-title":"Caspian J Intern Med"},{"key":"5049_CR125","doi-asserted-by":"publisher","first-page":"938102","DOI":"10.3389\/fendo.2023.938102","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Gao P, Sun W, Rehman AU, Jiang J, Xu S, et al. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Front Endocrinol (Lausanne). 2023;14:938102.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5049_CR126","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.3233\/THC-231470","volume":"32","author":"JL Lu","year":"2024","unstructured":"Lu JL, Yuan XY, Zhang JS, Li Y. Meta-analysis of the GALAD model for diagnosing primary hepatocellular carcinoma. Technol Health Care. 2024;32(5):3047\u201361.","journal-title":"Technol Health Care"},{"issue":"1","key":"5049_CR127","first-page":"8868370","volume":"2021","author":"F Xu","year":"2021","unstructured":"Xu F, Zhang L, He W, Song D, Ji X, Shao J. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients. Dis Markers. 2021;2021(1):8868370.","journal-title":"Dis Markers"},{"key":"5049_CR128","doi-asserted-by":"publisher","first-page":"191029","DOI":"10.1155\/2015\/191029","volume":"2015","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lu Y, Xu Q, Tang B, Park CK, Chen X. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Dis Markers. 2015;2015:191029.","journal-title":"Dis Markers"},{"key":"5049_CR129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.canlet.2019.04.016","volume":"454","author":"X Qu","year":"2019","unstructured":"Qu X, Alsager S, Zhuo Y, Shan B. HOX transcript antisense RNA (HOTAIR) in cancer. Cancer Lett. 2019;454:90\u20137.","journal-title":"Cancer Lett"},{"issue":"1","key":"5049_CR130","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12879-022-07292-8","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Chen Y, Tu S, Zhang J, Qiu Y, Yu W. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis. BMC Infect Dis. 2022;22(1):323.","journal-title":"BMC Infect Dis"},{"key":"5049_CR131","doi-asserted-by":"publisher","first-page":"1359414","DOI":"10.3389\/fmed.2024.1359414","volume":"11","author":"E Alemayehu","year":"2024","unstructured":"Alemayehu E, Belete MA, Walle M, Getu F, Mulatie Z, Teshome M, et al. Diagnostic accuracy of circulating miRNAs to discriminate hepatocellular carcinoma from liver cirrhosis: a systematic review and meta-analysis. Front Med (Lausanne). 2024;11:1359414.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"5049_CR132","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12885-022-09530-3","volume":"22","author":"Y Han","year":"2022","unstructured":"Han Y, Jiang W, Wang Y, Zhao M, Li Y, Ren L. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma. BMC Cancer. 2022;22(1):431.","journal-title":"BMC Cancer"},{"issue":"1","key":"5049_CR133","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-022-00409-w","volume":"10","author":"L Cab\u00fas","year":"2022","unstructured":"Cab\u00fas L, Lagarde J, Curado J, Lizano E, P\u00e9rez-Boza J. Current challenges and best practices for cell-free long RNA biomarker discovery. Biomark Res. 2022;10(1):62.","journal-title":"Biomark Res"},{"issue":"1","key":"5049_CR134","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2144\/000114306","volume":"59","author":"X Li","year":"2015","unstructured":"Li X, Mauro M, Williams Z. Comparison of plasma extracellular RNA isolation kits reveals kit-dependent biases. Biotechniques. 2015;59(1):13\u20137.","journal-title":"Biotechniques"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05049-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05049-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05049-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:01:30Z","timestamp":1789704090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05049-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5049"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05049-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was approved by the Research Ethics Committees of the National Institute for Medical Research Development (IR.NIMAD.REC.1404.063).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"578"}}